Literature DB >> 25612780

Transcriptional regulation of Mcl-1 plays an important role of cellular protective effector of vincristine-triggered autophagy in oral cancer cells.

Ming-Ju Hsieh1, Yi-Hsien Hsieh, Chiao-Wen Lin, Mu-Kuan Chen, Shun-Fa Yang, Hui-Ling Chiou.   

Abstract

OBJECTIVE: The autophagy-associated release of HMGB1 (high-mobility group box 1) has been reported that protect cancer cells from numerous chemotherapeutics. However, the related molecular mechanism involved in the protection of oral cancer cells remains unclear. RESEARCH DESIGN AND METHODS: In this study, we determined that HMGB1 released by oral cancer cells protected the cells against apoptosis caused by vincristine by upregulating the transcription of Mcl-1.
RESULTS: Extracellular HMGB1 seems to be required for the autophagy-mediated inhibition of apoptosis because the effect of autophagy protection was abolished by HMGB1 knockdown. Vincristine treatment increased the expression of Mcl-1 mRNA, but decreased the Mcl-1 protein expression. HMGB1 expression inhibited blocked the Mcl-1 transcription increase and reduced Mcl-1 expression, demonstrate that HMGB1 is required for the upregulation of Mcl-1 transcriptional, and thereby maintaining Mcl-1 protein expression levels is required for the survival of oral cancer cells by vincristine.
CONCLUSIONS: Collectively, this study suggested that the HMGB1-mediated Mcl-1 transcription upregulation is a key mechanism by which autophagy protects oral cancer cells against vincristine-induced apoptosis.

Entities:  

Keywords:  Mcl-1; apoptosis; autophagy; high-mobility group box 1; vincristine

Mesh:

Substances:

Year:  2015        PMID: 25612780     DOI: 10.1517/14728222.2014.998200

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  7 in total

Review 1.  Autophagy and Hallmarks of Cancer.

Authors:  Tianzhi Huang; Xiao Song; Yongyong Yang; Xuechao Wan; Angel A Alvarez; Namratha Sastry; Haizhong Feng; Bo Hu; Shi-Yuan Cheng
Journal:  Crit Rev Oncog       Date:  2018

2.  A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma.

Authors:  Chiao-Wen Lin; Ying-Erh Chou; Chia-Ming Yeh; Shun-Fa Yang; Chun-Yi Chuang; Yu-Fan Liu
Journal:  Oncotarget       Date:  2017-05-23

3.  HMGB1/RAGE axis mediates the apoptosis, invasion, autophagy, and angiogenesis of the renal cell carcinoma.

Authors:  Cun-Zao Wu; Jian-Jian Zheng; Yong-Heng Bai; Peng Xia; Hai-Cong Zhang; Yong Guo
Journal:  Onco Targets Ther       Date:  2018-08-01       Impact factor: 4.147

Review 4.  Myeloid cell leukemia-1 expression in cancers of the oral cavity: a scoping review.

Authors:  Su-Jung Choi; Neeti Swarup; Ji-Ae Shin; Seong-Doo Hong; Sung-Dae Cho
Journal:  Cancer Cell Int       Date:  2022-05-06       Impact factor: 6.429

5.  Circulating level of high mobility group box‑1 predicts the severity of community‑acquired pneumonia: Regulation of inflammatory responses via the c‑Jun N‑terminal signaling pathway in macrophages.

Authors:  Hsiang-Ling Wang; Shih-Ming Tsao; Chao-Bin Yeh; Ying-Erh Chou; Shun-Fa Yang
Journal:  Mol Med Rep       Date:  2017-06-30       Impact factor: 2.952

6.  Single Nucleotide Polymorphisms in HMGB1 Correlate with Lung Cancer Risk in the Northeast Chinese Han Population.

Authors:  Min Jiang; Xuelian Li; Xiaowei Quan; Xiaoying Li; Baosen Zhou
Journal:  Molecules       Date:  2018-04-04       Impact factor: 4.411

7.  Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma.

Authors:  Zhimin Tong; Alicia Mejia; Omkara Veeranki; Anuj Verma; Arlene M Correa; Rashmi Dokey; Viren Patel; Luisa Maren Solis; Barbara Mino; Riham Kathkuda; Jaime Rodriguez-Canales; Steven H Lin; Sunil Krishnan; Scott Kopetz; Mariela Blum; Jaffer A Ajani; Wayne L Hofstetter; Dipen M Maru
Journal:  Ther Adv Med Oncol       Date:  2019-07-25       Impact factor: 8.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.